A Novel Alternative to Environmental Monitoring to Detect Workers at Risk for Beryllium Exposure-Related Health Effects

REFERENCES

• Eisenbud, M.: Origins of the standard for control of beryllium disease (1947–1949). Environmental Research 27:79–88 (1982).
   PubMed Web of Science ®Google Scholar
• “The Occupational Safety and Health Act, a National Consensus Standard for Beryllium and Beryllium Compounds.” Code of Federal Regulations Title 29, Part 1910.1000, Table Z-2. 1970.. [ANSI Standard Z37.29].
   Google Scholar
• Van Dyke, M.V., J.W. Martyny, M.M. Mroz, et al.: Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am. J. Respir. Crit. Care. Med. 68:842–848 (2011).
   Google Scholar
• Kelleher, P.C., J.W. Martyny, M.M. Mroz, et al.: Beryllium particulate exposure and disease relations in a beryllium machining plant. J. Occup. Environ. Med. 43:238–249 (2001).
   PubMed Web of Science ®Google Scholar
• Kreiss, K., G.A. Day, and C.R. Schuler: Beryllium: A modern industrial hazard. Annu. Rev. Public Health 28:259–277 (2007).
   PubMed Web of Science ®Google Scholar
• Kreiss, K., M. Mroz, B. Zhen, H. Wiedemann, and B. Barna: Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup. Environ. Med. 54:605–612 (1977).
   Google Scholar
• Day, G.A., A.B. Stefaniak, S.A. Weston, and S.S. Tinkle: Beryllium exposure: Dermal and immunological considerations. Int. Arch. Occup. Environ. Health 79(2):161–164 (2006).
   PubMed Web of Science ®Google Scholar
• McCawley, M.A., M.S. Kent, and M.T. Berakis: Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk. Appl. Occup. Environ. Hyg. 16:631–638 (2001).
   PubMedGoogle Scholar
• McCawley, M.A.: Rationale for sampling deposited submicrometer beryllium particulate matter. J. Occup. Environ. Hyg. 12:789–793 (2009).
   Web of Science ®Google Scholar
• Thorat, D.D., T.N. Mahadevan, and D.K. Ghosh: Particle size distribution and respiratory deposition estimates of beryllium aerosols in an extraction and processing plant. Am. Ind. Hyg. Assoc. J. 64:522–527 (2003).
   Google Scholar
• Chauhan, S., R. D’Cruz, S. Faruqi, K.K. Singh, S. Varma, and M. Singh: Chemical warfare agents. Environ. Toxicol. Pharmacol. 26:113–122 (2008).
   PubMed Web of Science ®Google Scholar
• Kent, M.S., T.G. Robins, and A.K. Madl: Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility. Appl. Occup. Environ. Hyg. 16:539–558 (2001).
   PubMedGoogle Scholar
• American Thoracic Society/European Respiratory Society/World Association Sarcoidosis other Granulomatous Diseases Statement: Statement on Sarcoidosis. Am. J. Respir. Crit. Care. Med. 160:736–755 (1999).
   PubMed Web of Science ®Google Scholar
• Miller, M.R., J. Hankinson, and V. Brusasco: Standardization of spirometry. Eur. Respir. J. 26:319–338 (2005).
   PubMed Web of Science ®Google Scholar
• Popov, T., R. Gottschalk, R. Kolendowicz, J. Dolovich, P. Powers, and F.E. Hargreave: The evaluation of a cell dispersion method of sputum examination. Clin. Exp. Allergy 24:778–783 (1994).
   PubMed Web of Science ®Google Scholar
• Fireman, E., I. Topilsky, J. Greif, et al.: Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease. Respir. Med. 93:827–834 (1999).
   PubMed Web of Science ®Google Scholar
• Mroz, M.M., K. Kreiss, D. Lezotte, P.A. Campbell, and L.S. Newman: Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J. Allergy Clin. Immunol. 88:54–60 (1991).
   PubMed Web of Science ®Google Scholar
• Fireman, E., and Y. Lerman: Induced sputum in occupational lung diseases. Breathe 2:50–59 (2005).
   Google Scholar
• Martyny, J., M. Hoover, M. Mroz, et al.: Aerosols generated during beryllium machining. J. Occup. Environ. Med. 42:8–18 (2000).
   PubMed Web of Science ®Google Scholar
• Sackett, H.M., L.A. Maier, L.J. Silveira, et al.: Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J. Occup. Environ. Med. 46:953–961 (2004).
   PubMed Web of Science ®Google Scholar
• Fireman, E., M.R. Kramer, J. Kaufman, J. Müller-Quernheim, and Y. Lerman: Beryllium disease: First case reported in Israel. Isr. Med. Assoc. J. 3:224–225 (2001).
   PubMed Web of Science ®Google Scholar
• Fireman, E., M.R. Kramer, I. Priel, and Y. Lerman: Chronic beryllium disease among dental technicians in Israel. Sarcoidosis Vasc. Diffuse Lung Dis. 23:215–221 (2006).
   PubMed Web of Science ®Google Scholar
• Fireman, E., O. Mazor, M. Kramer, I. Priel, and Y. Lerman: Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel. Occup. Environ. Med. 67:631–635 (2010).
   PubMed Web of Science ®Google Scholar
• Schuler, C.R., M.S. Kent, and D.C. Deubner: Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am. J. Ind. Med. 47:195–205 (2005).
   PubMed Web of Science ®Google Scholar
• Aronchick, J.M., M.D. Rossman, and W.T. Miller: Chronic beryllium disease: Diagnosis, radiographic findings, and correlation with pulmonary function tests. Radiology 163:677–682 (1987).
   PubMed Web of Science ®Google Scholar
• Kriebek, D., N.L. Sprince, E.A. Eisen, I.A. Greaves, H.A. Feldman, and R.E. Greene: Beryllium exposure and pulmonary function: A cross sectional study of beryllium workers. Br. J. Ind. Med. 45:167–173 (1988).
   PubMedGoogle Scholar
• Rossman, M.D.: Chronic beryllium disease: Diagnosis and management Environ. Health Perspect. 104:945–947 (1996).
   Google Scholar
• Kantrow, S.P., K.C. Meyer, P. Kidd, and G. Raghu: The CD4/CD8ratio in BAL fluid is highly variable in sarcoidosis. Eur. Respir. J. 10:2716–2721 (1997).
   PubMed Web of Science ®Google Scholar
• Martin, A.K., D.G. Mack, M.T. Falta, et al.: Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression. J. Allergy Clin. Immunol. 128:1100–1106 (2011).
   PubMed Web of Science ®Google Scholar
• Fireman, Z., A. Osipov, S. Kivity, et al.: The use of induced sputum in the assessment of pulmonary involvement in Crohn's disease. Am. J. Gastroenterol. 95:730–734 (2000).
   PubMed Web of Science ®Google Scholar
• Scuster, M., T. Tschernig, N. Krugand, and R. Pabst: Lymphocytes migrate from blood onto bronchoalveoalar lavage and lung parenchyma in the asthma model of a brown Norway rat. Am. J. Respir. Crit. Care Med. 161:558–566 (2000).
   PubMed Web of Science ®Google Scholar
• Pabst R., and T. Tschering: Lymphocyte dynamics: Caution in interpreting BAL numbers. Thorax 52:1078–1080 (1997).
   PubMed Web of Science ®Google Scholar
• Stefaniak, A.B., S.J., Chipera, G.A. Day, et al.: Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: Implications for risk assessment. J. Toxicol. Environ. Health 71:1468–1481 (2008).
   PubMed Web of Science ®Google Scholar
• Fireman E., Y. Lerman, M. Stark, et al.: Detection of occult lung impairment in welders by induced sputum particles and breath oxidation. Am. J. Ind. Med. 51:503–511 (2008).
   PubMed Web of Science ®Google Scholar
• Fireman, E.M., Y. Lerman, E. Ganor, et al.: Induced sputum assessment in New York City firefighters exposed to World Trade Center dust. Environ. Health Perspect. 112:1564–1569 (2004).
   PubMed Web of Science ®Google Scholar
• Stark, M., Y. Lerman, A. Kapel, et al.: Biological exposure metrics of beryllium-exposed dental technicians. Arch. Environ. Occup. Health 69:89–99 (2014).
   PubMed Web of Science ®Google Scholar
• Stefaniak, A.B., M.A. Virji, and G.A. Day: Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid. Chemosphere 83:1181–1187 (2011).
   PubMed Web of Science ®Google Scholar
• Mukerjee, D., C.St. George, and J. Knight: Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology 43:461–466 (2004).
   PubMed Web of Science ®Google Scholar
• Fireman, E., J. Greif, Y. Schwarz, et al.: Assessment of hazardous dust exposure by BAL and induced sputum. Chest 115:1720–1728 (1999).
   PubMed Web of Science ®Google Scholar
• Salehi, F., J. Zayed, S. Audusseau, et al.: Immunological responses in C3H/HeJ mice following nose-only inhalation exposure. J. Appl. Toxicol. 29:61–68 (2009).
   PubMed Web of Science ®Google Scholar
• Curtis, G.H.: Cutaneous hypersensitivity due to beryllium: A study of thirteen cases. Arch. Dermat. Syph. 64:470–482 (1951).
   Google Scholar
• Fireman, E., A. Bar Shai, Y. Lerman, et al.: Chest wall shrapnel-induced chronic beryllium disease. Sarcoidosis Vasc. Diffuse Lung Dis. 29:147–150 (2012).
   PubMed Web of Science ®Google Scholar
• Tinkle, S.S., M.J. Antonini, B.A. Rich, et al.: Skin as a route of exposure and sensitization in chronic beryllium disease. Environ. Health Perspect. 111:1202–1208 (2003).
   PubMed Web of Science ®Google Scholar